I-Chemical contract Umkhiqizi-I-Blog
I-AASraw ikhiqiza izimpushana ze-NMN ne-NRC ngobuningi!

  Ukubuka konke kweSunitinib Malate Yini Esingayisebenzisela i-Sunitinib Malate? Isebenza Kanjani iSunitinib Malate? Ungayithatha Kanjani iSunitinib Malate? Ungayigcina Kanjani i-Sunitinib Malate? Sazi Kangakanani Imiphumela Emibi YeSunitinib Malate? Yiziphi Ezinye Izidakamizwa Ezizothinta I-Sunitinib Malate? I-FDA igunyaza iSunitinib Malate Njenge-Adjuvant Treatment Ye-Renal Cell Carcinoma Lapho Ingakwazi khona

Funda kabanzi

  I-Acalabrutinib Backgroud Ukubuyekezwa kwe-Acalabrutinib Ukwelashwa kwe-Acalabrutinib (Isetshenziselwe) I-Acalabrutinib Mechanism Of Action Iyini imiphumela emibi engaba khona ye-Acalabrutinib? I-Acalabrutinib VS Ibrutinib Research: I-Acalabrutinib Ekwelapheni I-lymphocytic leukemia (CLL) i-Acalabrutinib Backgroud Kuze kube manje, i-acalabrutinib isetshenzisiwe ezivivinyweni zokufunda ukwelashwa kwe-B-All, Myelofibrosis, Ovarian Cancer, Multiple Myeloma, neHodgkin Lym]

Funda kabanzi

  Cabozantinib Incazelo I-Cabozantinib Mechanism Of Action I-Cabozantinib Side Effects Ukuthuthukiswa Kwamuva Kwe-Cabozantinib Cabozantinib Treatment Success Stories Summary I-Cabozantinib Incazelo I-Cabozantinib (i-CAS: 849217-68-1) isetshenziselwa ukwelapha umdlavuza wezinso osezingeni eliphezulu, kwesinye isikhathi kuhlanganiswa nomunye umuthi obizwa nge-nivolumab. ICabozantinib nayo isetshenziselwa ukwelapha umdlavuza wesibindi kubantu abake baphathwa nge-sorafenib phambilini. I-Cabozantinib isetshenziselwa […]

Funda kabanzi

  Kuyini u-Erlotinib? Usebenza kanjani u-Erlotinib? Yiziphi Izifo Ezelashwa I-Erlotinib? Usetshenziswa Kanjani U-Erlotinib Okwamanje Emtholampilo? Iziphi Iziguli Lapho I-Erlotinib Iphumelela Kakhulu? Kuyini Ukumelana Ne-Erlotinib? Yiziphi Izingozi Ezihambisana no-Erlotinib? Yiziphi Izidakamizwa noma Izithasiselo Ezisebenzisana Ne-Erlotinib? Isifinyezo Sokwelashwa Esivunyelwe se-FDA Kuyini […]

Funda kabanzi